Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

144.77 +0.32 (+0.22%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,378,093
Open 145.00
Bid (Size) 144.55 (5)
Ask (Size) 144.89 (5)
Prev. Close 144.45
Today's Range 143.54 - 145.41
52wk Range 143.39 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
Johnson & Johnson reports first-quarter earnings, with adjusted EPS up 12.4% and sales up 2.3%. Analysts optimistic about stock's future, highlighting potential growth from new drug approvals. JNJ aims... 
Via Benzinga
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
Johnson & Johnson (NYSE: JNJ) reported better-than-expected first-quarter earnings on Tuesday. 
Via Benzinga

Performance

YTD
-9.50%
-9.50%
1 Month
-7.65%
-7.65%
3 Month
-9.81%
-9.81%
6 Month
-7.25%
-7.25%
1 Year
-12.62%
-12.62%

More News

Read More
Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough
Via InvestorPlace
Topics Economy
Exposures Interest Rates
Put $10,000 in These 3 Dividend Stocks by 2025
Via InvestorPlace
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Why Johnson & Johnson Stock Got Tossed by the Market Today
Via The Motley Fool
Johnson & Johnson (JNJ) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?
Via Benzinga
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
Via Benzinga
JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results
From Johnson & Johnson
Via Business Wire
Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook
Via Benzinga
Johnson & Johnson is as Cheap as it’s Going to Get
Via MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Macatawa Bank Corporation (Nasdaq - MCBC), Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN)
From Brodsky & Smith LLC
Via GlobeNewswire
Bellwether Health Giant J&J Beats Earnings Calls, But Shares Dip On Light Sales
Via Investor's Business Daily
Earnings Turnaround For Johnson & Johnson With Q1 2024 Financial Results
Via Talk Markets
Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges
Via InvestorPlace
Topics ETFs
Wall Street Braces For Mixed Open As Middle-East Tensions Offset Earnings Optimism: Analyst Points To Silver Lining In Rally Break
Via Benzinga
Topics Bonds
Exposures Debt Markets
Earnings Scheduled For April 16, 2024
Via Benzinga
Star Surgical Shines as U.S. Outlook Improves for 2024
Via MarketBeat
Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%
From Johnson & Johnson
Via Business Wire
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
Via Talk Markets
Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Via Benzinga
Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.